Aspire-Lakewood Holdings, Inc.
ASBPW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire-Lakewood Holdings, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $145.4K in total; no superinvestor holds it.
Other share classesASBP
Q1 2023 vs. Q4 2022
How the institutions holding Aspire-Lakewood Holdings, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 37 | 1 | 36 | 0 |
| Shares | 9.62M | 350.0K | 9.45M | +180.0K (+1.9%) |
| Value | $627.8K | $28.0K | $399.0K | −$200.8K (−33.5%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cohanzick Management, LLC | 166,667 | $6.97K | 0.01% |
Sold out (1)
Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| CVI Holdings, LLC | 24,600 | $1.97K |
Not filed for Q1 2023 yet (1)
Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Kepos Capital LP | 350,000 | $28.0K |